Conjunctival Melanoma and Cell-Free DNA Regression With Ipilimumab/Nivolumab and Stereotactic Radiosurgery. uri icon

Overview

publication date

  • August 15, 2023

Research

keywords

  • Conjunctival Neoplasms
  • Ipilimumab
  • Melanoma
  • Nivolumab
  • Radiosurgery

Identity

PubMed Central ID

  • PMC10867273

Scopus Document Identifier

  • 85189139089

Digital Object Identifier (DOI)

  • 10.1097/IOP.0000000000002490

PubMed ID

  • 37581882

Additional Document Info

volume

  • 40

issue

  • 3